Avisi Technologies Closes $4 Million Seed Round to Further Develop Glaucoma Treatment Device
Penn spinout Avisi Technologies raised $4.06 million in a seed round led by Accanto Partners.
Neuralert Technologies included in TIME’s List of the Best Inventions
The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.
PCI Ventures Presents at Pennovation Works Showcase
The PCI Ventures at Pennovation Works Showcase took place in October 2022, in celebration of Pennovation Works' 6th Anniversary and PCI Ventures' 12 years of service to the Penn community.
Penn spinout and I-Corps participant NeuroFlow raises $25 million growth round, doubles headcount and expands into Center City office
The funding will help Neuroflow, a Philadelphia-based mental health startup, make greater investments in research and development, expand its technology platform and increase headcount.
Philadelphia gene therapy company Passage Bio names former Novartis executive as new CEO
Philadelphia gene therapy company Passage Bio appointed Dr. Will Chou, former Novartis executive, as its new CEO.
Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research
The funds will allow Innervace to advance their platform and lead asset in Parkinson’s disease, which aims to reconstruct the neuronal circuitry that is lost in Parkinson's patients.
Penn Spinout Verismo Therapeutics Receives FDA Clearance of Investigational New Drug Application for SynKIR-110™, a KIR-CAR T Cell Immunotherapy Candidate
Verismo plans to begin enrolling patients in the first quarter of 2023 at the initial clinical site, the Hospital of the University of Pennsylvania.
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
The combined company, which is expected to operate under the name Carisma Therapeutics Inc., will focus on advancing Carisma’s proprietary cell therapy platform.
Penn spinout Capstan Therapeutics Launches with Goal of Incorporating mRNA into CAR-T Cell Therapy
This new approach to CAR-T therapy will involve mRNA therapy that directs cells in the body to make proteins to prevent or fight disease.
B.PHL Innovation Festival: PCIV Startup VasoWatch LLC and PCI I-Corps Participant Viora Health Featured
The event, which served as a gathering place for local and global creatives, entrepreneurs, leaders, students, and industry changemakers, featured some incredible Penn startups.